↓ Skip to main content

Toll-like receptor/interleukin-1 domain innate immune signalling pathway genetic variants are candidate predictors for severe gastrointestinal toxicity risk following 5-fluorouracil-based chemotherapy

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, November 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
15 Mendeley
Title
Toll-like receptor/interleukin-1 domain innate immune signalling pathway genetic variants are candidate predictors for severe gastrointestinal toxicity risk following 5-fluorouracil-based chemotherapy
Published in
Cancer Chemotherapy and Pharmacology, November 2018
DOI 10.1007/s00280-018-3729-y
Pubmed ID
Authors

Samantha K. Korver, Rachel J. Gibson, Joanne M. Bowen, Janet K. Coller

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 27%
Student > Ph. D. Student 3 20%
Researcher 2 13%
Professor 1 7%
Student > Doctoral Student 1 7%
Other 1 7%
Unknown 3 20%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 20%
Biochemistry, Genetics and Molecular Biology 3 20%
Unspecified 1 7%
Nursing and Health Professions 1 7%
Psychology 1 7%
Other 1 7%
Unknown 5 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2018.
All research outputs
#15,378,098
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#1,810
of 2,501 outputs
Outputs of similar age
#253,024
of 441,612 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#17
of 31 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,612 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.